JAM-B/VE-JAM Antibody (988905) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10744K
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Neutralization
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # 988905
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human JAM‑B/VE‑JAM
Phe29-Asn236
Accession # P57087
Phe29-Asn236
Accession # P57087
Specificity
Detects human JAM/VE-JAM in direct ELISAs
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for JAM-B/VE-JAM Antibody (988905) [DyLight 488]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: JAM-B/VE-JAM
Long Name
Junctional Adhesion Molecule B
Alternate Names
CD322, JAM2, JAMB, VE-JAM
Additional JAM-B/VE-JAM Products
Product Documents for JAM-B/VE-JAM Antibody (988905) [DyLight 488]
Product Specific Notices for JAM-B/VE-JAM Antibody (988905) [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...